A Rabbit Model for Testing Helper-Dependent Adenovirus-Mediated Gene Therapy for Vein Graft Atherosclerosis  Lianxiang Bi, Bradley K. Wacker, Emma Bueren,

Slides:



Advertisements
Similar presentations
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: SOCS1 Prevents Graft Arteriosclerosis by Preserving.
Advertisements

Transglutaminase activity regulates atherosclerotic plaque composition at locations exposed to oscillatory shear stress  Hanke L. Matlung, Annette E.
DOI: /j.atherosclerosis
The Role of ex-vivo Gene Therapy of Vein Grafts with Egr-1 Decoy in the Suppression of Intimal Hyperplasia  M. Peroulis, J. Kakisis, A. Kapelouzou, A.
Omega-6 polyunsaturated fatty acids prevent atherosclerosis development in LDLr-KO mice, in spite of displaying a pro-inflammatory profile similar to.
Volume 39, Issue 5, Pages (November 2013)
Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits by Yoshihiro Fukumoto,
Volume 62, Issue 6, Pages (December 2002)
Accelerated aneurysmal dilation associated with apoptosis and inflammation in a newly developed calcium phosphate rodent abdominal aortic aneurysm model 
Volume 62, Issue 3, Pages (March 2015)
Volume 43, Issue 6, Pages (December 2015)
Identification of Bone Marrow-Derived Soluble Factors Regulating Human Mesenchymal Stem Cells for Bone Regeneration  Tsung-Lin Tsai, Wan-Ju Li  Stem Cell.
Deiodinase 2 upregulation demonstrated in osteoarthritis patients cartilage causes cartilage destruction in tissue-specific transgenic rats  H. Nagase,
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 8, Issue 4, Pages (October 2008)
Inhibitory Effects of Calcitonin Gene-Related Peptides on Experimental Vein Graft Disease  Xiaoning Zhang, MD, Jian Zhuang, MD, Hongsui Wu, MB, Zhihong.
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes  Yoshitaka Miyagawa,
Volume 42, Issue 5, Pages (May 2015)
Volume 19, Issue 4, Pages (April 2011)
Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft  Mitsuteru Handa, MD, Wei Li,
Molecular Therapy - Methods & Clinical Development
Volume 22, Issue 1, Pages (July 2015)
Molecular Therapy - Methods & Clinical Development
Volume 15, Issue 3, Pages (March 2012)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Differential expression of interleukin-17 and interleukin-22 in inflamed and non-inflamed synovium from osteoarthritis patients  C. Deligne, S. Casulli,
Molecular Therapy - Methods & Clinical Development
Volume 39, Issue 5, Pages (November 2013)
International Journal of Cardiology
Volume 12, Issue 4, Pages (October 2010)
Volume 14, Issue 6, Pages (December 2011)
Volume 25, Issue 11, Pages (November 2017)
Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype  Motoaki Ohnaka, MD, Akira Marui, MD, PhD,
Molecular Therapy - Nucleic Acids
Michael A. Rosenbaum, MD, Keiko Miyazaki, MD, Scott M. Colles, Linda M
Spatiotemporal expression and localization of matrix metalloproteinas-9 in a murine model of thoracic aortic aneurysm  Jeffrey A. Jones, PhD, John R.
Volume 14, Issue 10, Pages (March 2016)
Volume 29, Issue 6, Pages (December 2008)
Volume 22, Issue 1, Pages (January 2018)
Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype  Hector F. Simosa, MD, Grace Wang, MD, XinXin Sui,
Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft  Mitsuteru Handa, MD, Wei Li,
IL-27 Suppresses Antimicrobial Activity in Human Leprosy
The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression  John R. Hoch, MD, Vida K. Stark,
Volume 1, Issue 2, Pages (February 2005)
Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma  Alessandra Lopes, Kevin Vanvarenberg, Véronique Préat,
Volume 9, Issue 5, Pages (May 2009)
Molecular Therapy - Methods & Clinical Development
Volume 20, Issue 12, Pages (December 2012)
Volume 17, Issue 8, Pages (November 2016)
Julia Ma, Christophe Pichavant, Haley du Bois, Mital Bhakta, Michele P
Volume 15, Issue 3, Pages (March 2012)
Molecular Therapy - Methods & Clinical Development
R. Parekh, M.K. Lorenzo, S.Y. Shin, A. Pozzi, A.L. Clark 
Volume 8, Issue 5, Pages (November 2008)
Xiaoyue Pan, Yuxia Zhang, Li Wang, M. Mahmood Hussain  Cell Metabolism 
Immunosuppressive treatment of aortic allografts
Volume 20, Issue 3, Pages (March 2012)
An external, oversized, porous polyester stent reduces vein graft neointima formation, cholesterol concentration, and vascular cell adhesion molecule.
Cell Therapy in Myology: Dynamics of Muscle Precursor Cell Death after Intramuscular Administration in Non-human Primates  Daniel Skuk, Jacques P. Tremblay 
Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice  Abbey Schepers, MD, Nuno M.M. Pires,
Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts  Hiroshi Banno, MD, Yoshifumi Takei, PhD,
P.J. Moss, W. Huang, J. Dawes, K. Okuse, S.B. McMahon, A.S.C. Rice 
Molecular Therapy - Methods & Clinical Development
Volume 23, Issue 10, Pages (June 2018)
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes  Yoshitaka Miyagawa,
Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma  Myoung Sook Han, Tamera Barrett, Michael.
Fig. 2. Col IV–Ac2-26 NPs increase subendothelial collagen in Ldlr−/− mice with established atherosclerosis. Col IV–Ac2-26 NPs increase subendothelial.
Fig. 3. Col IV–Ac2-26 NPs suppress lesional superoxide and increase lesional Il10 mRNA in Ldlr−/− mice with established atherosclerosis. Col IV–Ac2-26.
Molecular Therapy - Methods & Clinical Development
Volume 4, Issue 4, Pages (October 2006)
Presentation transcript:

A Rabbit Model for Testing Helper-Dependent Adenovirus-Mediated Gene Therapy for Vein Graft Atherosclerosis  Lianxiang Bi, Bradley K. Wacker, Emma Bueren, Ervin Ham, Nagadhara Dronadula, David A. Dichek  Molecular Therapy - Methods & Clinical Development  Volume 7, Pages 96-111 (December 2017) DOI: 10.1016/j.omtm.2017.09.004 Copyright © 2017 The Authors Terms and Conditions

Figure 1 Study Protocols (A) Vein graft atherosclerosis study. Rabbits were begun on a 0.3% cholesterol diet. Their plasma cholesterols were measured after 2 weeks on diet and every 2 weeks thereafter. On the basis of these measurements, the cholesterol content of each rabbit’s diet was adjusted (0.25%, 0.125%, or 0% cholesterol), with a goal of achieving plasma cholesterols of 200–800 mg/dL. Vein grafts were placed after 4 weeks of high-fat diet, HDAdNull was infused into the grafts 4 weeks later, and the grafts were harvested 4, 12, or 20 weeks after HDAdNull infusion. (B) Vein graft inflammation study. Vein grafts were placed in chow-fed rabbits. 4 weeks later, grafts were infused with vehicle (DMEM), HDAdNull, or FGAdNull. Grafts were harvested either 2 or 8 weeks later. Molecular Therapy - Methods & Clinical Development 2017 7, 96-111DOI: (10.1016/j.omtm.2017.09.004) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Plasma Cholesterol Concentrations in Rabbits Fed a High-Fat Diet Vein graft surgery was performed after 4 weeks on diet, with HDAdNull infusion 4 weeks later. Rabbits are separated into 3 cohorts based on time of harvest (4, 12, or 20 weeks after vector infusion, with data represented in blue, red, and green, respectively). Data are mean ± SD. Molecular Therapy - Methods & Clinical Development 2017 7, 96-111DOI: (10.1016/j.omtm.2017.09.004) Copyright © 2017 The Authors Terms and Conditions

Figure 3 Vector Genomes and Inflammatory Cytokine Expression in Vein Grafts Harvested from Hyperlipidemic Rabbits DNA and RNA were extracted from vein grafts harvested 4 (n = 8), 12 (n = 10), or 20 weeks (n = 9) after HDAdNull infusion. (A) Vector DNA was measured by qPCR. (B–F) Levels of mRNA encoding (B) MCP-1, (C) IL-1β, (D) IL-6, (E) TNF-α, and (F) IFN-γ were measured with qRT-mediated PCR, with normalization to GAPDH mRNA in the same samples. AU, arbitrary units. Data points are individual grafts; bars are group means ± SEM. p values are from ANOVA, with correction for pairwise post hoc comparisons. Molecular Therapy - Methods & Clinical Development 2017 7, 96-111DOI: (10.1016/j.omtm.2017.09.004) Copyright © 2017 The Authors Terms and Conditions

Figure 4 Morphometry of Vein Grafts Harvested from Hyperlipidemic Rabbits Grafts were harvested 4 (n = 7), 12 (n = 10), or 20 weeks (n = 9) after HDAdNull infusion. Three segments of each of the grafts were embedded, sectioned, and stained with Verhoef van Gieson stain. Images of stained sections were analyzed with computer-assisted planimetry to determine (A) intimal area, (B) medial area, (C) intima/media area ratio, (D) lumen diameter, (E) lumen area, and (F) percent lumen stenosis. Data points are values for individual grafts; bars are group means ± SEM. p values are from ANOVA, with correction for pairwise post hoc comparisons (see also Figure S2). Molecular Therapy - Methods & Clinical Development 2017 7, 96-111DOI: (10.1016/j.omtm.2017.09.004) Copyright © 2017 The Authors Terms and Conditions

Figure 5 Cellularity, Adhesion Molecule Expression, and Lipid Accumulation in Vein Grafts Harvested from Hyperlipidemic Rabbits Grafts were harvested 4 (n = 8), 12 (n = 10), or 20 weeks (n = 9) after HDAdNull infusion. (A–E) Three segments of each of the grafts were embedded, sectioned, and stained with antibodies or oil red O. Images of stained sections were analyzed with computer-assisted planimetry to determine the percentage of intimal area stained for (A) muscle actin (HHF-35 antibody); (B) macrophages (RAM-11 antibody); (C) ICAM-1; (D) VCAM-1; and (E) neutral lipid (oil red O [ORO]). (F) Lipid was extracted from each of the grafts, and total cholesterol content was measured with mass spectrometry. Data points are values for individual grafts; bars are group means ± SEM. p values are from ANOVA, with correction for pairwise post hoc comparisons. (G–I) Representative sections of vein grafts harvested 12 weeks after vector infusion and stained with (G) HHF-35 antibody, (H) RAM-11 antibody, or (I) ORO. Dashed lines indicate internal elastic lamina. Scale bars, 500 μm. Inset in (G) shows HHF-35-positive area in intima (arrow). M, media; I, intima. Scale bar, 200 μm (see also Figures S3–S5). Molecular Therapy - Methods & Clinical Development 2017 7, 96-111DOI: (10.1016/j.omtm.2017.09.004) Copyright © 2017 The Authors Terms and Conditions

Figure 6 Vector Genomes and Inflammatory Cytokine Expression in Vein Grafts Harvested from Chow-Fed Rabbits 4 weeks after placement, grafts were infused with DMEM, HDAdNull, or FGAdNull and harvested 2 weeks (n = 7, 8, and 5, respectively) or 8 weeks later (n = 12, 9, and 8, respectively). (A) Vector DNA was measured by qPCR. (B–F) Levels of mRNA encoding (B) MCP-1, (C) IL-1β, (D) IL-6, (E) TNF-α, and (F) IFN-γ were measured with qRT-mediated PCR, with normalization to GAPDH mRNA in the same samples. AU, arbitrary units. Data points are individual grafts; bars are group means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001. p values are from rank-sum tests. Molecular Therapy - Methods & Clinical Development 2017 7, 96-111DOI: (10.1016/j.omtm.2017.09.004) Copyright © 2017 The Authors Terms and Conditions

Figure 7 Morphometry of Vein Grafts Harvested from Chow-Fed Rabbits 4 weeks after placement, grafts were infused with DMEM, HDAdNull, or FGAdNull and harvested 2 weeks (n = 7, 8, and 5, respectively) or 8 weeks later (n = 8, 9, and 8, respectively). Three segments of each of the grafts were embedded, sectioned, and stained with Verhoef van Gieson stain. Images of stained sections were analyzed with computer-assisted planimetry to determine (A) intimal area; (B) medial area; (C) intima/media area ratio; (D) lumen diameter; (E) lumen area; and (F) percent lumen stenosis. Data points are values for individual grafts; bars are group means ± SEM. *p < 0.05 (from t test) (see also Figure S6). Molecular Therapy - Methods & Clinical Development 2017 7, 96-111DOI: (10.1016/j.omtm.2017.09.004) Copyright © 2017 The Authors Terms and Conditions

Figure 8 Cellularity and Adhesion Molecule Expression in Vein Grafts Harvested from Chow-Fed Rabbits 4 weeks after placement, grafts were infused with DMEM, HDAdNull, or FGAdNull and harvested 2 weeks (n = 7, 8, and 5, respectively) or 8 weeks later (n = 8, 9, and 8, respectively). Three segments of each of the grafts were embedded, sectioned, and stained with antibodies. Images of stained sections were analyzed with computer-assisted planimetry to determine the percentage of intimal area stained for (A) T cells (KEN-5 antibody); (B) macrophages (RAM-11 antibody); (C) ICAM-1; and (D) VCAM-1. Data points are mean values for individual grafts; bars are group means ± SEM. *p < 0.05; **p < 0.01. p values are from t tests (A–C) and rank-sum test (D) (see also Figures S7–S10). Molecular Therapy - Methods & Clinical Development 2017 7, 96-111DOI: (10.1016/j.omtm.2017.09.004) Copyright © 2017 The Authors Terms and Conditions